Desperate Hacker

Chapter 581 Speed ​​Up

Anne Yang left Malaysia.

Now she must take down Japan's Professor Yamanaka.

The professor graduated from Kyoto University and has been conducting research in Japan for many years. But to be honest, the island country’s 16 Nobel Prizes in 16 years are really not just talk.

Professor Yamanaka studies stem cell treatments.

Simply put, it uses the patient's own stem cells to repair damaged organs.

In this regard, Professor Yamanaka is the pioneer of the principle.

He successfully isolated a completely new type of cell from skin cells.

The research team is currently studying how to use this stem cell to repair damage to the human pancreas.

Simply put, if this research is successful.

Then diabetes may no longer be a disease that cannot be cured and can only be maintained by lifelong medication.

It is said that their team's research is close to clinical trials.

But the problem is that at this time, for unknown reasons, his research funding was withdrawn. At the same time, several large pharmaceutical companies also suspended funding for his research.

Only Yang Anni, who is in the industry, knows the inside story.

Various hypoglycemic drugs and various insulins developed by large pharmaceutical companies are the main source of annual profits.

There are not a few people suffering from diabetes around the world.

And the medical insurance in most countries also covers this disease.

Once there is a treatment, the problem of diabetes can be solved once and for all.

The anti-diabetic drugs developed by many large companies at high prices will face the market disappearing.

Therefore, Professor Yamanaka’s research is not bad, but it is still advancing too fast for large pharmaceutical groups.

After Annie Yang's plane landed in Tokyo.

Soon she used her status as a Princeton pharmaceutical executive to directly or indirectly contact Professor Yamanaka through various channels.

Finally the other party agreed to meet and talk with her.

So in an eel restaurant, this scholar in his 50s was surprised to see a beautiful mixed-race woman in her 30s sitting opposite him.

"Professor Yamanaka, if your research progress is as expected, it should have been suspended by now!"

"No! Our research is still continuing..."

"I heard that the two funds you applied for were just rejected by officials from the Ministry of Education, Culture, Sports, Science and Technology?"

"They said it was because of lack of funds..."

"I heard that your research team has received funding from large pharmaceutical groups before, but they seem to be planning to withdraw funding in this area!"

Professor Yamanaka looked at the woman suspiciously.

The other party is an executive of a large American pharmaceutical group. If it weren't for this identity, Professor Yamanaka would not waste time going out to have dinner with her, no matter how beautiful she was.

The beautiful women that scientists like are not women who look smart and cunning.

This kind of woman cannot be held in the hands of anyone, especially a simple-minded person like him.

"Professor Yamanaka! I heard that you and your wife are not on good terms? In addition, there is a female doctor in your laboratory who seems to admire you very much..."

"You are talking nonsense..."

"Would you like to think about taking your team to another place? What do you think of going to the United States?" "Hey..."

Professor Yamanaka sighed.

"It is impossible for me to go to the United States...because I still have family here. Americans may be willing to accept me, but they are not willing to accept my parents..."

"Okay! How about we change places and go to China?"

"China? Do you know what it means for me to do that? It means betraying the entire Japanese academic community..."

"But the current academic world does not support your promising research! If someone is willing to provide you with a generous grant, there is no upper limit on the grant, and China is so close to Japan, you can fly back and forth every week as long as you want. Between the two countries! Even your experimental team here does not need to stop, and you do not need to worry that research will be restricted..."

"Will such a good thing happen? But will my research be used for other purposes? I refuse to cooperate with any foreign official organization!"

"But what if it's a private institution? Let me put it this way! A friend of mine unfortunately suffers from a rare type of lymphoma. The only treatment at present is to take flotaxin!"

"I know that medicine! He will die sooner or later. Unfortunately, my research can't help him. The lymphatic system is very complex and cannot be solved by just one organ..."

"Yes! But your research can delay the side effects of drugs on his kidneys, heart, and liver. Once the research is successful, you can even repair the problems caused by these side effects..."

When Professor Yamanaka heard this, his heart suddenly seemed to move.

If he is willing, how much research funding will he provide?

Annie Yang handed over a checkbook.

"What do you mean?"

"You can use as much as you want. This rich man holds a large oil field with a reserve of 10 billion tons! Do you think that as long as you agree, you will still lack research funds?"

……

A few days later.

A private research institution in Lin'an suddenly broke a piece of news in the domestic academic circle.

Professor Yamanaka, a Nobel Prize-level researcher from Japan, announced that he has joined this little-known private research team.

As soon as the news came out, the entire domestic academic circle was excited.

Even the mailbox posted by this research institution on the recruitment website that day was immediately filled with resumes from graduates of top medical schools across the country.

At the same time, Japan was also extremely shocked.

Kyoto University, where Professor Yamanaka works, even came to him specifically and asked him to explain this matter.

After learning that Professor Yamanaka would not give up his laboratory at Kyoto University, the university reluctantly approved a smaller research grant.

But there are some things that were okay to do before, but it’s too late to do them now.

But compared with the shocking news released by that domestic research institution.

Foreign cancer funds are much more low-key.

Because they suddenly announced the acquisition of an artificial intelligence team established independently by the original Google team.

Because the team’s research direction is the involvement of artificial intelligence in pharmaceutical decision-making and protein design.

Compared with the currently popular mainstream large language models, this is not attractive to the market.

So the acquisition was a small price to pay.

And it didn’t make any splash in the industry.

However, the founder of the team did not expect that the person who acquired him was actually a student he had taught.

"Gentlemen! We have had a relationship before. I provide you with research funds, and you can study the direction you are currently researching, but what I need is to find a solution to the rare lymphoma that my client has. treatment plan, if you want your team to survive longer, you'd better speed up some research progress, because as long as that gentleman lives long enough, your company can survive long enough!"

(End of this chapter)